• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

托雷斯海峡地区日本脑炎疫苗加强剂量间隔时间的评估。

An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait.

作者信息

Hanna Jeffrey N, Smith Greg A, McCulloch Bradley G, Taylor Carmel T, Pyke Alyssa T, Brookes Dianne L

机构信息

Tropical Public Health Unit Network, Queensland Health, Cairns.

出版信息

Aust N Z J Public Health. 2005 Feb;29(1):44-7. doi: 10.1111/j.1467-842x.2005.tb00747.x.

DOI:10.1111/j.1467-842x.2005.tb00747.x
PMID:15782871
Abstract

OBJECTIVE

Japanese encephalitis (JE) emerged for the first time in the Torres Strait, north Australia, in 1995. The inactivated mouse-brain derived JE vaccine was offered to all residents of the outer Torres Strait Islands prior to the 1996 wet season. This study was undertaken to determine the appropriateness of the recommended three-year interval between booster doses of the vaccine.

METHODS

JE neutralising antibody was measured in residents of Badu Island for whom 30-36 months had passed since either a previous booster or the completion of the primary immunisation series.

RESULTS

Only 70 (32%) of 219 eligible individuals had protective antibodies; 50 (37%) of the adults were immune, compared with 20 (24%) of the children (odds ratio (OR) 1.93; 95% confidence interval (CI) 1.01-3.74).

CONCLUSIONS

This low level of immunity suggests that there is little in the way of natural boosting from either JE or other closely related viruses. Given the apparent low level of risk of exposure to the JE virus in the Torres Strait, and the logistical complexities involved in delivering the booster doses, the current recommendation of a three-year interval is not inappropriate.

IMPLICATIONS

It would be advantageous to have a JE vaccine that is not only safer but also more immunogenic, so that it might be possible to further increase the booster dose interval.

摘要

目的

1995年,日本脑炎(乙脑)首次在澳大利亚北部的托雷斯海峡出现。在1996年雨季来临之前,为托雷斯海峡外岛的所有居民提供了源自鼠脑的灭活乙脑疫苗。本研究旨在确定推荐的疫苗加强剂量之间三年间隔的合理性。

方法

对巴杜岛居民进行乙脑中和抗体检测,这些居民自上次加强免疫或完成基础免疫系列后已过去30 - 36个月。

结果

219名符合条件的个体中,只有70人(32%)具有保护性抗体;50名成年人(37%)有免疫力,而儿童中有20人(24%)有免疫力(优势比(OR)1.93;95%置信区间(CI)1.01 - 3.74)。

结论

这种低水平的免疫力表明,无论是乙脑还是其他密切相关病毒,自然增强免疫力的作用都很小。鉴于托雷斯海峡接触乙脑病毒的风险明显较低,以及提供加强剂量所涉及的后勤复杂性,目前推荐的三年间隔并非不合适。

启示

拥有一种不仅更安全而且免疫原性更强的乙脑疫苗将是有利的,这样有可能进一步延长加强剂量的间隔时间。

相似文献

1
An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait.托雷斯海峡地区日本脑炎疫苗加强剂量间隔时间的评估。
Aust N Z J Public Health. 2005 Feb;29(1):44-7. doi: 10.1111/j.1467-842x.2005.tb00747.x.
2
Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.初免和加强免疫接种乙型脑炎疫苗的交叉保护作用:一项为期两年的随访研究。
Vaccine. 2013 Dec 17;32(1):119-23. doi: 10.1016/j.vaccine.2013.10.055. Epub 2013 Oct 28.
3
Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.初免一剂vero 细胞培养灭活流行性乙型脑炎疫苗(JE-VC)后的长期免疫原性,以及既往接种过鼠脑源灭活流行性乙型脑炎疫苗儿童再次接种JE-VC 疫苗的安全性和免疫原性。
Vaccine. 2018 Mar 7;36(11):1398-1404. doi: 10.1016/j.vaccine.2018.01.075.
4
Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.日本脑炎嵌合病毒疫苗的长期随访:儿童的免疫反应
Vaccine. 2016 Nov 4;34(46):5664-5669. doi: 10.1016/j.vaccine.2016.09.018. Epub 2016 Sep 27.
5
Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.单剂量日本脑炎嵌合病毒疫苗在幼儿中的长期免疫原性及初次免疫后5年的加强免疫反应
Pediatr Infect Dis J. 2017 Apr;36(4):e108-e113. doi: 10.1097/INF.0000000000001494.
6
Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.在泰国儿童中,用SA14-14-2疫苗进行初次接种后,以日本脑炎嵌合病毒疫苗作为加强剂量的免疫原性。
Vaccine. 2016 Oct 17;34(44):5279-5283. doi: 10.1016/j.vaccine.2016.09.005. Epub 2016 Sep 12.
7
Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.使用日本脑炎灭活疫苗加强免疫六年后抗体的持续性。
Vaccine. 2015 Jul 9;33(30):3600-4. doi: 10.1016/j.vaccine.2015.05.037. Epub 2015 May 30.
8
Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.在菲律宾,使用日本脑炎嵌合病毒疫苗(JE-CV)加强针后,JE-CV 疫苗接种儿童的抗体持续存在 5 年。
J Infect Dis. 2018 Jan 30;217(4):567-571. doi: 10.1093/infdis/jix601.
9
Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.中国东部省份浙江的乙型脑炎血清分子流行病学
PLoS Negl Trop Dis. 2016 Aug 25;10(8):e0004936. doi: 10.1371/journal.pntd.0004936. eCollection 2016 Aug.
10
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.嵌合型减毒活乙型脑炎疫苗(ChimeriVax-JE):安全性和免疫原性的2期临床试验、疫苗剂量和接种程序的效果以及对灭活乙型脑炎抗原攻击的记忆反应
J Infect Dis. 2003 Oct 15;188(8):1213-30. doi: 10.1086/378356. Epub 2003 Oct 3.

引用本文的文献

1
The Japanese encephalitis virus NS1' protein facilitates virus infection in mosquitoes.日本脑炎病毒NS1'蛋白促进病毒在蚊子中的感染。
PLoS Negl Trop Dis. 2025 Jan 27;19(1):e0012823. doi: 10.1371/journal.pntd.0012823. eCollection 2025 Jan.
2
Long-term neurological and healthcare burden of adults with Japanese encephalitis: A nationwide study 2000-2015.2000-2015 年日本脑炎成人患者的长期神经和医疗保健负担:一项全国性研究。
PLoS Negl Trop Dis. 2021 Sep 14;15(9):e0009703. doi: 10.1371/journal.pntd.0009703. eCollection 2021 Sep.
3
Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
日本脑炎疫苗:免疫原性、保护效力、有效性及对疾病负担的影响
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-18. doi: 10.1080/21645515.2017.1285472. Epub 2017 Feb 22.
4
A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.一剂vero 细胞来源的日本脑炎(JE)疫苗(Ixiaro)可有效增强已接种鼠脑来源 JE 疫苗旅行者的免疫力。
Clin Infect Dis. 2012 Sep;55(6):825-34. doi: 10.1093/cid/cis542. Epub 2012 Jun 13.
5
Development of a vaccine to prevent Japanese encephalitis: a brief review.开发预防日本脑炎的疫苗:简要回顾。
Int J Gen Med. 2009 Dec 29;2:195-200. doi: 10.2147/ijgm.s6281.
6
Domestic pigs and Japanese encephalitis virus infection, Australia.澳大利亚的家猪与日本脑炎病毒感染
Emerg Infect Dis. 2008 Nov;14(11):1736-8. doi: 10.3201/eid1411.071368.
7
Vaccines for preventing Japanese encephalitis.预防日本脑炎的疫苗。
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004263. doi: 10.1002/14651858.CD004263.pub2.